Leuzinger Dias Catarina, Maio Inês, Brandão José Ricardo, Tomás Edite, Martins Esmeralda, Santos Silva Ermelinda
Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal.
Gastroenterology Unit, Paediatrics Division, Child and Adolescent Department, Centro Materno-Infantil do Norte, Centro Hospitalar Universitário do Porto, Porto, Portugal.
GE Port J Gastroenterol. 2019 Oct;26(6):430-437. doi: 10.1159/000496571. Epub 2019 Mar 14.
The prevalence of non-alcoholic fatty liver disease (NAFLD) affecting children and adolescents has increased dramatically in recent years. This increase is most probably related to the obesity pandemic and the high consumption of fructose. However, hepatic steatosis has some rare causes (e.g., some metabolic diseases) of which clinicians should be aware, particularly (but not only) when patients are non-obese or non-overweight. Differential diagnosis is notably important when pathologies have a specific treatment, such as for glycogenosis type IX (GSD-IX).
To contribute to the knowledge on the differential diagnosis of NAFLD in paediatric age and to the clinical, biochemical, molecular, and histological characterisations of GSD-IX, a rare metabolic disorder.
We performed a retrospective study of a small series of cases ( = 3) of GSD-IX diagnosed in the past 6 years, who were currently being followed up in the Units of Gastroenterology or Metabolic Diseases of the Paediatric Division of our hospital and whose clinical presentation was NAFLD in paediatric age.
Three male patients were diagnosed with NAFLD before 2 years of age, 2 with confirmed diagnosis before the age of 3 years (alanine aminotransferase [ALT], liver ultrasound, and molecular analysis) and 1 whose diagnosis was confirmed at 11 years (ALT, liver ultrasound, liver histology, and molecular analysis). None of the patients were obese or overweight, and the daily fructose consumption was unknown. The outcome was favourable in all 3 patients, with follow-up periods ranging from 2 to 6 years.
The decision on how far the search for secondary causes of NAFLD should go can be difficult, and GSD-IX must be on the list of possible causes.
近年来,影响儿童和青少年的非酒精性脂肪性肝病(NAFLD)患病率急剧上升。这种上升很可能与肥胖流行和果糖的高消耗量有关。然而,肝脂肪变性有一些罕见病因(如某些代谢疾病),临床医生应予以关注,特别是(但不限于)当患者非肥胖或非超重时。当病理情况有特定治疗方法时,如对于IX型糖原贮积病(GSD-IX),鉴别诊断尤为重要。
有助于了解儿童期NAFLD的鉴别诊断知识,并有助于了解GSD-IX这一罕见代谢紊乱疾病的临床、生化、分子和组织学特征。
我们对过去6年诊断的一小系列(n = 3)GSD-IX病例进行了回顾性研究,这些病例目前在我院儿科胃肠病学或代谢疾病科接受随访,其临床表现为儿童期NAFLD。
3例男性患者在2岁前被诊断为NAFLD,2例在3岁前确诊(丙氨酸转氨酶[ALT]、肝脏超声和分子分析),1例在11岁时确诊(ALT、肝脏超声、肝脏组织学和分子分析)。所有患者均非肥胖或超重,每日果糖摄入量未知。所有3例患者的预后良好,随访期为2至6年。
对于NAFLD继发性病因的排查应到何种程度的决策可能很困难,GSD-IX必须列入可能的病因清单。